Chris Meduri, MD MPH @chrismeduri tweet - It is with great pleasure to announce the completion of the DurAVR EFS enrollment! Thank you @umichCVC. This first-in-class biomimetic valve exceeded already remarkable prior results. More details next week in San Fran @TCTMD and in London as a LBCT @PCRonline. @AnterisTech #tavr https://t.co/TkP4e8lEE6

Chris Meduri, MD MPH

@chrismeduri

2 years

It is with great pleasure to announce the completion of the DurAVR EFS enrollment! Thank you @umichCVC. This first-in-class biomimetic valve exceeded already remarkable prior results. More details next week in San Fran @TCTMD and in London as a LBCT @PCRonline. @AnterisTech #tavr

Replies

Joe Doyle

@Rocket2010

2 years

@chrismeduri @umichCVC @TCTMD @PCRonline @AnterisTech @ShinFukuharaMD @azeemlatib @DrTomWaggoner @tavrkapadia @TAVRBot @CEOPaterson @hahn_rt @JoaoLCavalcante Thank you Chris and team for the amazing job you did in coordinating this study. Can’t wait to hear about the results in detail. #TAVR #DurAVR. $AVR